華北製藥(600812.SH)下屬與石家莊市土地儲備中心簽訂《企、事業單位國有土地使用權收購(回)合同》
格隆匯3月3日丨華北製藥(600812.SH)公佈,根據2019年11月5日石家莊市主城區污染工業企業退城搬遷改造領導小組辦公室《關於進一步做好我市污染工業企業退城搬遷有關工作的通知》的有關要求,近日,石家莊市土地儲備中心與公司下屬子公司華北製藥華勝有限公司(以下簡稱“華勝公司”)簽訂了《企、事業單位國有土地使用權收購(回)合同》。根據公司及下屬子公司相關制度規定,本次《合同》簽訂已履行華勝公司內部審議程序,無需履行公司董事會審議程序。本事項不構成關聯交易,亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
本次《合同》簽訂,是華勝公司依照石家莊市主城區工業企業退城搬遷改造和石家莊市整體建設規劃的統一要求進行的,對公司生產經營不會產生影響。後續公司其他地塊將根據工作進展陸續簽署土地收購合同。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.